Loretta Little is a Managing Director of WRF Capital. She focuses on investment opportunities in the life sciences such as medical devices, health care IT, biotechnology and scientific instrumentation. Her portfolio includes consumer technology, software and advanced materials companies. She has worked closely with several of WRF Capital’s investments, including Clarisonic (acquired by L’Oreal), Mirador Biomedical (acquired by Centurion Medical Products), Amnis (acquired by EMD Millipore), Mobisante (acquired by Renew Group), and EKOS (acquired by BTG plc). She oversees WRF Capital’s investments in Cardiac Insight, FlexMinder, Modumetal, Nexgenia, C-SATS, Cardeas Pharma, Accium Biosciences, Shippable, Phytelligence and Transformative Med.

Previously, Ms. Little served as senior technology licensing manager at Washington Research Foundation. Before joining WRF, she worked as a marketing manager for a biotechnology company and as a market consultant.

Ms. Little received an MBA from the University of Arizona and a B.A. in zoology from Pomona College. She currently serves as a board member with the Alliance of Angels and WINGS—The Washington Medical Technology Angel Network.